BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28238045)

  • 1. Estimation of the cumulative incidence function under multiple dependent and independent censoring mechanisms.
    Lok JJ; Yang S; Sharkey B; Hughes MD
    Lifetime Data Anal; 2018 Apr; 24(2):201-223. PubMed ID: 28238045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
    Willems S; Schat A; van Noorden MS; Fiocco M
    Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parametric likelihood inference for interval censored competing risks data.
    Hudgens MG; Li C; Fine JP
    Biometrics; 2014 Mar; 70(1):1-9. PubMed ID: 24400873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating predictors of competing risk outcomes when censoring depends on time-dependent covariates, with application to safety and efficacy of HIV treatment.
    Lok JJ; Hughes MD
    Stat Med; 2016 Jun; 35(13):2183-94. PubMed ID: 26763556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias.
    Howe CJ; Cole SR; Chmiel JS; Muñoz A
    Am J Epidemiol; 2011 Mar; 173(5):569-77. PubMed ID: 21289029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association analysis of successive events data in the presence of competing risks.
    Chen X; Cheng Y; Frank E; Kupfer DJ
    Stat Methods Med Res; 2018 Jun; 27(6):1661-1682. PubMed ID: 27647813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smooth semi-nonparametric (SNP) estimation of the cumulative incidence function.
    Duc AN; Wolbers M
    Stat Med; 2017 Aug; 36(18):2921-2934. PubMed ID: 28543626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weighted estimation of the accelerated failure time model in the presence of dependent censoring.
    Cho Y; Ghosh D
    PLoS One; 2015; 10(4):e0124381. PubMed ID: 25909753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonparametric binary instrumental variable analysis of competing risks data.
    Richardson A; Hudgens MG; Fine JP; Brookhart MA
    Biostatistics; 2017 Jan; 18(1):48-61. PubMed ID: 27354709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)-estimation of adverse event risks.
    Stegherr R; Schmoor C; Beyersmann J; Rufibach K; Jehl V; Brückner A; Eisele L; Künzel T; Kupas K; Langer F; Leverkus F; Loos A; Norenberg C; Voss F; Friede T
    Trials; 2021 Jun; 22(1):420. PubMed ID: 34187527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receiver operating characteristic curve estimation for time to event with semicompeting risks and interval censoring.
    Jacqmin-Gadda H; Blanche P; Chary E; Touraine C; Dartigues JF
    Stat Methods Med Res; 2016 Dec; 25(6):2750-2766. PubMed ID: 24803510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection Bias Due to Loss to Follow Up in Cohort Studies.
    Howe CJ; Cole SR; Lau B; Napravnik S; Eron JJ
    Epidemiology; 2016 Jan; 27(1):91-7. PubMed ID: 26484424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards.
    Díaz I; Colantuoni E; Hanley DF; Rosenblum M
    Lifetime Data Anal; 2019 Jul; 25(3):439-468. PubMed ID: 29492746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.
    Kawahara T; Shinozaki T; Matsuyama Y
    BMC Med Res Methodol; 2020 Jul; 20(1):204. PubMed ID: 32736528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved confidence intervals for a difference of two cause-specific cumulative incidence functions estimated in the presence of competing risks and random censoring.
    Scosyrev E
    Biom J; 2020 Oct; 62(6):1394-1407. PubMed ID: 32227361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.
    Geskus RB
    Biometrics; 2011 Mar; 67(1):39-49. PubMed ID: 20377575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semiparametric regression on cumulative incidence function with interval-censored competing risks data and missing event types.
    Park J; Bakoyannis G; Zhang Y; Yiannoutsos CT
    Biostatistics; 2022 Jul; 23(3):738-753. PubMed ID: 33417707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring.
    Schaubel DE; Wei G
    Biometrics; 2011 Mar; 67(1):29-38. PubMed ID: 20560935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring.
    Dong G; Mao L; Huang B; Gamalo-Siebers M; Wang J; Yu G; Hoaglin DC
    J Biopharm Stat; 2020 Sep; 30(5):882-899. PubMed ID: 32552451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Proportional Hazards Regression Model for the Sub-distribution with Covariates Adjusted Censoring Weight for Competing Risks Data.
    He P; Eriksson F; Scheike TH; Zhang MJ
    Scand Stat Theory Appl; 2016 Mar; 43(1):103-122. PubMed ID: 27034534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.